DeSchuytner Brian
Insider CIK 1782163 · MRSN Sr. VP., FIN, Product Strategy
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 3,515 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 7,734 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 4,009 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,500 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,750 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 800 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 250 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 9,422 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 1,077 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 6,381 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 818 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 4,218 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 281 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 4,172 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 327 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 2,671 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 178 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | D To issuer deriv | 2026-01-06 | 2026-01-06 | 5,590 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | U Tender | 2026-01-06 | 2026-01-06 | 5,015 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-16 | 2025-01-17 | 8,470 | $0.58 | $4.9K | 121,393 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-15 | 2025-01-17 | 6,250 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-01-15 | 2025-01-17 | 62,500 | — | $0 | 62,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2025-01-15 | 2025-01-17 | 281,250 | — | $0 | 281,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-15 | 2025-01-17 | 14,583 | — | $0 | 43,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-15 | 2025-01-16 | 2,331 | $0.63 | $1.5K | 109,030 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-15 | 2025-01-17 | 14,583 | — | $0 | 129,863 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-15 | 2025-01-17 | 6,250 | — | $0 | 115,280 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-14 | 2025-01-16 | 6,250 | — | $0 | 6,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2025-01-14 | 2025-01-15 | 3,713 | $0.66 | $2.5K | 105,111 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-14 | 2025-01-16 | 6,250 | — | $0 | 111,361 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2025-01-13 | 2025-01-15 | 10,000 | — | $0 | 20,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2025-01-13 | 2025-01-15 | 10,000 | — | $0 | 108,824 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2024-10-03 | 2024-10-07 | 5,598 | $1.96 | $11.0K | 94,824 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2024-10-02 | 2024-10-07 | 8,089 | $2.00 | $16.2K | 100,422 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-07 | 50,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-10-01 | 2024-10-07 | 50,000 | — | $0 | 108,511 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2024-01-16 | 2024-01-17 | 9,327 | $2.71 | $25.3K | 54,511 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-01-15 | 2024-01-17 | 262,500 | — | $0 | 262,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-15 | 2024-01-17 | 3,958 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-15 | 2024-01-17 | 6,250 | — | $0 | 6,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2024-01-15 | 2024-01-17 | 58,333 | — | $0 | 58,333 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-15 | 2024-01-17 | 6,250 | — | $0 | 59,880 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-15 | 2024-01-17 | 3,958 | — | $0 | 63,838 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-14 | 2024-01-17 | 6,250 | — | $0 | 12,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-14 | 2024-01-17 | 6,250 | — | $0 | 55,630 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2024-01-13 | 2024-01-17 | 10,000 | — | $0 | 30,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2024-01-13 | 2024-01-17 | 10,000 | — | $0 | 47,380 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-09-05 | 2023-09-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2023-01-17 | 2023-01-18 | 5,131 | $5.74 | $29.5K | 32,781 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2023-01-15 | 2023-01-18 | 6,250 | — | $0 | 12,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2023-01-15 | 2023-01-18 | 3,958 | — | $0 | 3,958 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2023-01-15 | 2023-01-18 | 6,250 | — | $0 | 33,954 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2023-01-15 | 2023-01-18 | 3,958 | — | $0 | 37,912 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2023-01-14 | 2023-01-18 | 6,250 | — | $0 | 18,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2023-01-14 | 2023-01-18 | 6,250 | — | $0 | 27,704 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-01-13 | 2023-01-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2023-01-13 | 2023-01-18 | 180,000 | — | $0 | 180,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-19 | 3,958 | — | $0 | 7,916 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-19 | 6,250 | — | $0 | 18,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 112,500 | — | $0 | 112,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2022-01-14 | 2022-01-19 | 10,208 | — | $0 | 17,573 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2021-01-15 | 2021-01-20 | 3,959 | — | $0 | 11,874 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 112,500 | — | $0 | 112,500 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | F Tax w/h | 2021-01-15 | 2021-01-20 | 1,162 | $21.09 | $24.5K | 6,423 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2021-01-15 | 2021-01-20 | 3,959 | — | $0 | 7,585 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-01-15 | 2020-01-16 | 71,250 | — | $0 | 71,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2020-01-15 | 2020-01-16 | 15,833 | — | $0 | 15,833 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-07-10 | 2019-07-12 | 240,000 | — | $0 | 240,000 | SEC↗ |